NIBEC Co., Ltd.

KOSDAQ:A138610 Stock Report

Market Cap: ₩201.8b

NIBEC Past Earnings Performance

Past criteria checks 3/6

NIBEC has been growing earnings at an average annual rate of 16.4%, while the Biotechs industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 20.5% per year. NIBEC's return on equity is 15.5%, and it has net margins of 22.6%.

Key information

16.42%

Earnings growth rate

-2.22%

EPS growth rate

Biotechs Industry Growth11.70%
Revenue growth rate20.48%
Return on equity15.52%
Net Margin22.56%
Last Earnings Update31 Mar 2026

Recent past performance updates

Recent updates

Analysis Article • Dec 11

Revenues Not Telling The Story For NIBEC Co., Ltd. (KOSDAQ:138610) After Shares Rise 42%

Despite an already strong run, NIBEC Co., Ltd. ( KOSDAQ:138610 ) shares have been powering on, with a gain of 42% in...
Analysis Article • Nov 11

Here's Why NIBEC (KOSDAQ:138610) Can Manage Its Debt Responsibly

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Sep 26

NIBEC Co., Ltd.'s (KOSDAQ:138610) Price Is Right But Growth Is Lacking After Shares Rocket 28%

The NIBEC Co., Ltd. ( KOSDAQ:138610 ) share price has done very well over the last month, posting an excellent gain of...
Analysis Article • Aug 08

Is NIBEC (KOSDAQ:138610) Weighed On By Its Debt Load?

KOSDAQ:A138610 1 Year Share Price vs Fair Value Explore NIBEC's Fair Values from the Community and select yours Howard...
Analysis Article • May 29

NIBEC Co., Ltd. (KOSDAQ:138610) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected

Despite an already strong run, NIBEC Co., Ltd. ( KOSDAQ:138610 ) shares have been powering on, with a gain of 41% in...
Analysis Article • Apr 10

NIBEC Co., Ltd.'s (KOSDAQ:138610) Shares Climb 26% But Its Business Is Yet to Catch Up

NIBEC Co., Ltd. ( KOSDAQ:138610 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Apr 09

Is NIBEC (KOSDAQ:138610) Using Debt In A Risky Way?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Nov 13

More Unpleasant Surprises Could Be In Store For NIBEC Co., Ltd.'s (KOSDAQ:138610) Shares After Tumbling 34%

NIBEC Co., Ltd. ( KOSDAQ:138610 ) shareholders won't be pleased to see that the share price has had a very rough month...
Analysis Article • Oct 14

Does NIBEC (KOSDAQ:138610) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analysis Article • Jun 18

Is NIBEC (KOSDAQ:138610) Weighed On By Its Debt Load?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article • Mar 28

NIBEC Co., Ltd.'s (KOSDAQ:138610) Share Price Not Quite Adding Up

There wouldn't be many who think NIBEC Co., Ltd.'s ( KOSDAQ:138610 ) price-to-sales (or "P/S") ratio of 12.5x is worth...
Analysis Article • Apr 05

NIBEC (KOSDAQ:138610) Has Debt But No Earnings; Should You Worry?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Jan 04

NIBEC (KOSDAQ:138610) Has Rewarded Shareholders With An Exceptional 411% Total Return On Their Investment

Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...

Revenue & Expenses Breakdown

How NIBEC makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A138610 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2632,3437,2987,2075,613
31 Dec 2532,7194,6428,7535,613
30 Sep 2532,9603,13710,4524,074
30 Jun 2533,577-2,43715,0884,074
31 Mar 2523,739-11,06813,5244,074
31 Dec 2424,550-9,32712,4134,074
30 Sep 2422,812-7,84816,7300
30 Jun 2419,407-4,84311,8530
31 Mar 2417,578-5,89011,1420
31 Dec 2315,704-6,28410,4900
30 Sep 2316,213-11,6726,2305,361
30 Jun 2317,493-8,1575,2585,361
31 Mar 2318,878-5,1637,1574,402
31 Dec 2221,670-3,76612,3900
30 Sep 2220,077-6789,192806
30 Jun 2220,776-8468,0521,492
31 Mar 2218,766-3,3405,2223,735
31 Dec 2113,625-5,7404,6123,333
30 Sep 2112,682-4,4193,9033,356
30 Jun 219,383-5,5193,3202,937
31 Mar 217,225-4,8342,5961,957
31 Dec 206,357-3,6382,4111,535
30 Sep 206,775-2,3142,0871,354
30 Jun 207,971-1,8302,4821,358
31 Mar 208,949-2,2352,6671,646
31 Dec 199,287-2,7272,6821,683
30 Sep 197,803-3,5892,9511,640
30 Jun 196,664-4,0222,5881,453
31 Mar 195,717-4,0212,5501,347
31 Dec 185,208-4,1462,3951,204
30 Sep 185,085-4,5562,3731,134
30 Jun 185,326-4,1272,2371,065
31 Mar 185,223-3,4062,018644
31 Dec 176,303-2,5682,210641
30 Sep 176,219-1,6832,399228
30 Jun 175,890-2,3832,724292
31 Mar 175,849-2,2802,834256
31 Dec 164,804-3,0272,848252
30 Sep 164,589-2,8232,532169
30 Jun 164,600-2,3542,413108
31 Mar 164,645-2,5862,418120
31 Dec 154,174-2,4262,248114
30 Sep 153,915-2,3172,23890
30 Jun 154,010-2,5532,42059

Quality Earnings: A138610 has high quality earnings.

Growing Profit Margin: A138610 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A138610 has become profitable over the past 5 years, growing earnings by 16.4% per year.

Accelerating Growth: A138610 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A138610 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (22.6%).

Return on Equity

High ROE: A138610's Return on Equity (15.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/19 04:52
End of Day Share Price 2026/06/19 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NIBEC Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.